Oak Grove Capital’s iShares Biotechnology ETF IBB Stock Holding History

Oak Grove Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,300	Closed	-$251K	–	76
2019 Q2	$251K	Sell	2,300 -100	-4%	-$10.6K	0.13%	62
2019 Q1	$268K	Hold	2,400	–	–	0.17%	60
2018 Q4	$231K	Hold	2,400	–	–	0.21%	56
2018 Q3	$293K	Hold	2,400	–	–	0.25%	45
2018 Q2	$264K	Sell	2,400 -1,535	-39%	-$164K	0.27%	41
2018 Q1	$420K	Sell	3,935 -9,044	-70%	-$1M	0.46%	34
2017 Q4	$1.39M	Buy	+12,979	New	+$1.39M	1.44%	18

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Oak Grove Capital's IBB Position: Q3 2019 in Review

Oak Grove Capital sold out of iShares Biotechnology ETF (IBB) in Q3 2019, closing a stake of 2,300 shares — an estimated $251K sold.

Oak Grove Capital first reported a position in IBB in Q4 2017 and held it in 7 quarters. The position peaked at $1.39M in Q4 2017. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

Oak Grove Capital reported no remaining iShares Biotechnology ETF position as of Q3 2019 after selling out during the quarter.
Oak Grove Capital sold 2,300 iShares Biotechnology ETF shares in Q3 2019, an estimated $251K.
Oak Grove Capital first reported a position in iShares Biotechnology ETF in Q4 2017 and held it in 7 quarters.
Oak Grove Capital's iShares Biotechnology ETF position peaked at $1.39M in Q4 2017.
597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Oak Grove Capital's 13F filing for Q3 2019, filed 30 Oct 2019.